In addition, other survival analysis revealed that clinicopathological features including clinical stage, differentiation, HER2 status, and treatment were significant parameters affecting the survival time of GC patients (Table 3, supplementary Tables 1–3). Here, ERBB2 is linked to gastric cancer.